154 related articles for article (PubMed ID: 35324523)
1. Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models.
Shen Z; Pei Q; Zhang H; Yang C; Cui H; Li B; Liu J; Bo Z; Wei F; Zhang M; Liu C
Anticancer Drugs; 2022 Jul; 33(6):587-594. PubMed ID: 35324523
[TBL] [Abstract][Full Text] [Related]
2. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
[TBL] [Abstract][Full Text] [Related]
4. Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma.
Deng Z; Teng YJ; Zhou Q; Ouyang ZG; Hu YX; Long HP; Hu MJ; Mei S; Lin FX; Dai XJ; Zhang BY; Feng T; Tian XF
World J Gastrointest Oncol; 2021 Nov; 13(11):1725-1740. PubMed ID: 34853646
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia promotes conversion to a stem cell phenotype in prostate cancer cells by activating HIF-1α/Notch1 signaling pathway.
Wu K; Wu M; Yang H; Diao R; Zeng H
Clin Transl Oncol; 2023 Jul; 25(7):2138-2152. PubMed ID: 36757381
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
[TBL] [Abstract][Full Text] [Related]
8. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of Reactive Oxygen Species in Osteosarcoma and Potential Treatment Applications.
Sun W; Wang B; Qu XL; Zheng BQ; Huang WD; Sun ZW; Wang CM; Chen Y
Cells; 2019 Dec; 9(1):. PubMed ID: 31905813
[TBL] [Abstract][Full Text] [Related]
10. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol Induces Apoptosis in Murine Prostate Cancer Cells via Hypoxia-Inducible Factor 1-alpha (HIF-1α)/Reactive Oxygen Species (ROS)/P53 Signaling.
Wang D; Gao Z; Zhang X
Med Sci Monit; 2018 Dec; 24():8970-8976. PubMed ID: 30531685
[TBL] [Abstract][Full Text] [Related]
12. Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis.
Chang CC; Lin MT; Lin BR; Jeng YM; Chen ST; Chu CY; Chen RJ; Chang KJ; Yang PC; Kuo ML
J Natl Cancer Inst; 2006 Jul; 98(14):984-95. PubMed ID: 16849681
[TBL] [Abstract][Full Text] [Related]
13. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
[TBL] [Abstract][Full Text] [Related]
15. The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth.
Ban HS; Kim BK; Lee H; Kim HM; Harmalkar D; Nam M; Park SK; Lee K; Park JT; Kim I; Lee K; Hwang GS; Won M
Cell Death Dis; 2017 Jun; 8(6):e2843. PubMed ID: 28569777
[TBL] [Abstract][Full Text] [Related]
16. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
[TBL] [Abstract][Full Text] [Related]
17. PGE2-HIF1α reciprocal induction regulates migration, phenotypic alteration and immunosuppressive capacity of macrophages in tumor microenvironment.
Saha J; Sarkar D; Pramanik A; Mahanti K; Adhikary A; Bhattacharyya S
Life Sci; 2020 Jul; 253():117731. PubMed ID: 32353431
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
19. Berberine inhibits the expression of hypoxia induction factor-1alpha and increases the radiosensitivity of prostate cancer.
Zhang Q; Zhang C; Yang X; Yang B; Wang J; Kang Y; Wang Z; Li D; Huang G; Ma Z; Sun X; Cai J; Tao G; Dai S; Mao W; Ma J
Diagn Pathol; 2014 May; 9():98. PubMed ID: 24886405
[TBL] [Abstract][Full Text] [Related]
20. HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.
Zhu G; Tang Y; Geng N; Zheng M; Jiang J; Li L; Li K; Lei Z; Chen W; Fan Y; Ma X; Li L; Wang X; Liang X
Neoplasia; 2014 Feb; 16(2):168-79. PubMed ID: 24709424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
